Corticosteroid-responsive pharmacodynamic transcriptional markers: Results from a randomised placebo-controlled study of rheumatoid arthritis patients treated with prednisolone

被引：0
|
作者：
Dickson, Marion C. [1 ]
Ellis, Joanne [1 ]
Cai, Gengqian [2 ]
Wilson, Anthony G. [3 ]
Bridges, S. Louis, Jr. [4 ]
Furst, Daniel E. [5 ]
O'Dell, James R. [6 ]
El-Gabalawy, Hani S. [7 ]
Tiffany, Courtney [8 ]
Sidiqq, Shabanna [2 ]
Bal, Joanne [9 ]
Uings, Iain J. [1 ]
Binks, Michael H. [1 ]
机构：
[1] GSK, Stevenage, Herts, England
[2] GSK, Upper Merion, PA USA
[3] Univ Sheffield, Sheffield, S Yorkshire, England
[4] Univ Alabama, Birmingham, W Midlands, England
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Univ Nebraska, Omaha, NE 68182 USA
[7] Univ Manitoba, Winnipeg, MB, Canada
[8] GSK, Philadelphia, PA USA
[9] GSK, Greenford, Middx, England
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S774 / S774
页数：1
相关论文
共 50 条
  • [31] A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritis
    Soubrier, M.
    Lambert, C.
    Combe, B.
    Gaudin, P.
    Thomas, T.
    Sibilia, J.
    Dougados, M.
    Dubost, J-J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : 1056 - 1060
  • [32] TREATMENT RESPONSE TO RITUXIMAB IN COMBINATION WITH LEFLUNOMIDE IS INFLUENCED BY ANTICCP STATUS IN ACTIVE RHEUMATOID ARTHRITIS: RESULTS FROM A MULTICENTER RANDOMISED PLACEBO-CONTROLLED INVESTIGATOR INITIATED CLINICAL TRIAL IN ACTIVE RHEUMATOID ARTHRITIS (AMARA-STUDY)
    Koehm, M.
    Rossmanith, T.
    Alten, R.
    Aringer, M.
    Backhauss, M.
    Burmester, G.
    Feist, E.
    Herrmann, E.
    Kellner, H.
    Lehn, A.
    Mueller-Ladner, U.
    Rubbert-Roth, A.
    Tony, H. -P.
    Wassenberg, S.
    Burkhardt, H.
    Behrens, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1315 - 1315
  • [33] Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)
    Bingham, Clifton O., III
    Rizzo, Warren
    Kivitz, Alan
    Hassanali, Azra
    Upmanyu, Ruchi
    Klearman, Micki
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (05) : 818 - 822
  • [34] SAFETY AND EFFECTIVENESS OF LEFLUNOMIDE IN THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, PHASE-II STUDY
    MLADENOVIC, V
    DOMLJAN, Z
    ROZMAN, B
    JAJIC, I
    MIHAJLOVIC, D
    DORDEVIC, J
    POPOVIC, M
    DIMITRIJEVIC, M
    ZIVKOVIC, M
    CAMPION, G
    MUSIKIC, P
    LOWFRIEDRICH, I
    OED, C
    SEIFERT, H
    STRAND, V
    ARTHRITIS AND RHEUMATISM, 1995, 38 (11): : 1595 - 1603
  • [35] Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
    Smolen, J. S.
    Emery, P.
    Ferraccioli, G. F.
    Samborski, W.
    Berenbaum, F.
    Davies, O. R.
    Koetse, W.
    Purcaru, O.
    Bennett, B.
    Burkhardt, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (05) : 843 - 850
  • [36] Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
    Hafstrom, Ingiald
    Engvall, Inga-Lill
    Ronnelid, Johan
    Boonen, Annelies
    van der Heijde, Desiree
    Svensson, Bjorn
    BMJ OPEN, 2014, 4 (07):
  • [37] Pharmacodynamic Effects of Nipocalimab in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA): Results from the Multicenter, Randomized, Double-blinded, Placebo-controlled Phase 2A IRIS-RA Study
    Panchakshari, Rohit
    Loza, Matthew
    Huizinga, Thomas
    Schett, Georg
    Ma, Keying
    Leu, Jocelyn H.
    Liva, Sophia G.
    Ibrahim, Fowzia
    Zhou, Bei
    Wang, Qingmin
    Cella, Ricardo Rojo
    Karyekar, Chetan S.
    Fei, Kaiyin
    Cuff, Carolyn
    Gao, Sheng
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4231 - 4232
  • [38] Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
    McInnes, Iain B.
    Thompson, Liz
    Giles, Jon T.
    Bathon, Joan M.
    Salmon, Jane E.
    Beaulieu, Andre D.
    Codding, Christine E.
    Carlson, Timothy H.
    Delles, Christian
    Lee, Janet S.
    Sattar, Naveed
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (04) : 694 - 702
  • [39] Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
    Smolen, Josef S.
    Beaulieu, Andre
    Rubbert-Roth, Andrea
    Ramos-Remus, Cesar
    Rovensky, Josef
    Alecock, Emma
    Woodworth, Thasia
    Alten, Rieke
    LANCET, 2008, 371 (9617): : 987 - 997
  • [40] A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis
    JA Snowden
    JC Biggs
    ST Milliken
    A Fuller
    D Staniforth
    F Passuello
    J Renwick
    PM Brooks
    Bone Marrow Transplantation, 1998, 22 : 1035 - 1041
12345